medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Número 5

<< Anterior Siguiente >>

Ann Hepatol 2012; 11 (5)


Liver transplantation in the critically ill: donation after cardiac death compared to donation after brain death grafts

Taner CB, Bulatao IG, Arasi LC, Perry DK, Willingham DL, Sibulesky L, Rosser BG, Canabal JM, Nguyen JH, Kramer DJ

Idioma: Ingles.
Referencias bibliográficas: 16
Paginas: 679-685
Archivo PDF: 90.55 Kb.


RESUMEN

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Olson JC, Wendon JA, Kramer DJ, Arroyo V, et al. Intensive care of the patient with cirrhosis. Hepatology 2011; 54: 1864-72.

  2. Merion RM, Pelletier SJ, Goodrich N, et al. Donation after cardiac death as a strategy to increase deceased donor liver availability. Annals of Surgery 2006; 244: 555-62.

  3. Foley DP, Fernandez LA, Leverson G, Anderson M, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surgery 2011; 253: 817-25.

  4. Jay CL, Lyuksemburg V, Kang R, Preczewski L, et al. The increased cost of donation after cardiac death liver transplantation. Ann Surg 2010; 251(4): 743-8.

  5. Dubbeld J, van Hoek B, Ringers J. Use of a liver from donor after cardiac death: is it appropriate for the sick or the stable? Current Opinion Organ Trans 2011; 16: 239-42.

  6. Schaubel DE, Sima CS, Goodrich NP, et al. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplantation 2008; 8: 419-25.

  7. Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, et al. Liver Transplantation Using Controlled Donation After Cardiac Death Donors: An Analysis of a Large Single-Center Experience. Liver Transplantation 2009; 15: 1028-35.

  8. Taner CB, Bulatao IG, Willingham DL, et al. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transplantation 2012; 18(1): 100-11.

  9. Institute of Medicine DoHCS. Non-heart-beating organ transplantation: In: Medical and Ethical Issues in Procurement. Washington, DC: National Academy Press; 1997.

  10. Freeman RB. Mortality risk versus other end-points: who should come first on the liver transplant list? Liver Transplantation 2004; 10: 675-7.

  11. Findlay JY, Fix OK, Paugam-Burtz C, et al. Critical care of the end-stage liver disease patient awating liver transplantation. Liver Transplantation 2011; 17: 496-510.

  12. Skaro AI, Wang E, Lyuksemburg V, Abecassis M. Donation after cardiac death liver transplantation: time for policy to catch up with practice. Liver Transplantation 2012; 18: 5-8.

  13. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplantation 2006; 6: 783-90.

  14. Scientific Registry of Transplant Recipients. Available from: www.ustransplant.org [Accessed on January 16, 2012].

  15. Ozhathil DK, Li YF, Smith JK, et al. Impact of center volume on outcomes of increased-risk liver transplants. Liver Transplantation 2011; 17: 1191-9.

  16. Maluf DG, Stravitz RT, Cotterell AH, et al. Adult living donor versus deceased donor liver transplantation: a 6-year single center experience. Am J Transplantation 2005; 5: 419-25.




2020     |     www.medigraphic.com